These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36458331)

  • 81. Chronic diazoxide treatment decreases fat mass and improves endurance capacity in an obese mouse model of Prader-Willi syndrome.
    Bischof JM; Wevrick R
    Mol Genet Metab; 2018 Apr; 123(4):511-517. PubMed ID: 29506955
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Attenuation of the polypeptide 7B2, prohormone convertase PC2, and vasopressin in the hypothalamus of some Prader-Willi patients: indications for a processing defect.
    Gabreëls BA; Swaab DF; de Kleijn DP; Seidah NG; Van de Loo JW; Van de Ven WJ; Martens GJ; van Leeuwen FW
    J Clin Endocrinol Metab; 1998 Feb; 83(2):591-9. PubMed ID: 9467579
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A Novel Mutation of
    D Hidalgo-Santos A; Del Carmen DeMingo-Alemany M; Moreno-Macián F; Roselló M; Orellana C; Martínez F; Caro-Llopis A; León-Cariñena S; Tomás-Vila M
    Int J Endocrinol Metab; 2018 Jul; 16(3):e67329. PubMed ID: 30323850
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Hypothalamic growth hormone-releasing hormone (GHRH) cell number is increased in human illness, but is not reduced in Prader-Willi syndrome or obesity.
    Goldstone AP; Unmehopa UA; Swaab DF
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):743-55. PubMed ID: 12780752
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A review of clinical trials of oxytocin in Prader-Willi syndrome.
    Rice LJ; Einfeld SL; Hu N; Carter CS
    Curr Opin Psychiatry; 2018 Mar; 31(2):123-127. PubMed ID: 29206687
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Recommendations for the investigation of animal models of Prader-Willi syndrome.
    Resnick JL; Nicholls RD; Wevrick R;
    Mamm Genome; 2013 Jun; 24(5-6):165-78. PubMed ID: 23609791
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.
    Francis SM; Sagar A; Levin-Decanini T; Liu W; Carter CS; Jacob S
    Brain Res; 2014 Sep; 1580():199-218. PubMed ID: 24462936
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Emergent role of astrocytes in oxytocin-mediated modulatory control of neuronal circuits and brain functions].
    Baudon A; Clauss Creusot E; Charlet A
    Biol Aujourdhui; 2022; 216(3-4):155-165. PubMed ID: 36744981
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Prader-Willi syndrome imprinting centre deletion mice have impaired baseline and 5-HT2CR-mediated response inhibition.
    Davies JR; Wilkinson LS; Isles AR; Humby T
    Hum Mol Genet; 2019 Sep; 28(18):3013-3023. PubMed ID: 31087031
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Hypothalamic AAV-BDNF gene therapy improves metabolic function and behavior in the
    Queen NJ; Zou X; Anderson JM; Huang W; Appana B; Komatineni S; Wevrick R; Cao L
    Mol Ther Methods Clin Dev; 2022 Dec; 27():131-148. PubMed ID: 36284766
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Hypothalamic loss of Snord116 and Prader-Willi syndrome hyperphagia: the buck stops here?
    Rodriguez JA; Zigman JM
    J Clin Invest; 2018 Mar; 128(3):900-902. PubMed ID: 29376891
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Magel2-null mice are hyper-responsive to setmelanotide, a melanocortin 4 receptor agonist.
    Bischof JM; Van Der Ploeg LH; Colmers WF; Wevrick R
    Br J Pharmacol; 2016 Sep; 173(17):2614-21. PubMed ID: 27339818
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Immunohistochemical localization of oxytocin receptors in human brain.
    Boccia ML; Petrusz P; Suzuki K; Marson L; Pedersen CA
    Neuroscience; 2013 Dec; 253():155-64. PubMed ID: 24012742
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Leptin signaling defects in a mouse model of Prader-Willi syndrome: An orphan genetic obesity syndrome no more?
    Colmers WF; Wevrick R
    Rare Dis; 2013; 1():e24421. PubMed ID: 25002992
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Heteromerization of Dopamine D2 and Oxytocin Receptor in Adult Striatal Astrocytes.
    Amato S; Averna M; Guidolin D; Ceccoli C; Gatta E; Candiani S; Pedrazzi M; Capraro M; Maura G; Agnati LF; Cervetto C; Marcoli M
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902106
    [TBL] [Abstract][Full Text] [Related]  

  • 96. MAGEL2 (patho-)physiology and Schaaf-Yang syndrome.
    Schubert T; Schaaf CP
    Dev Med Child Neurol; 2025 Jan; 67(1):35-48. PubMed ID: 38950199
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi syndrome.
    Dykens EM; Miller J; Angulo M; Roof E; Reidy M; Hatoum HT; Willey R; Bolton G; Korner P
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925684
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [As early as birth, oxytocin plays a key role in both food and social behavior].
    Muscatelli F
    Biol Aujourdhui; 2022; 216(3-4):131-143. PubMed ID: 36744979
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Loss of magel2, a candidate gene for features of Prader-Willi syndrome, impairs reproductive function in mice.
    Mercer RE; Wevrick R
    PLoS One; 2009; 4(1):e4291. PubMed ID: 19172181
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Grey matter volume and cortical structure in Prader-Willi syndrome compared to typically developing young adults.
    Manning KE; Tait R; Suckling J; Holland AJ
    Neuroimage Clin; 2018; 17():899-909. PubMed ID: 29527494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.